Save time and get answers to complex questions with AI chat
Quartette side effects?Motegrity ingredients?Xiaflex market launch year?Complera manufacturer?Does lipitor's use influence blood pressure medication type?
See the DrugPatentWatch profile for xarelto
Short answer: As of now (2026‑08‑02) a generic 20 mg Xarelto (rivaroxaban) is not yet on the market in the United States. The U.S. patents and data‑exclusivity periods are still in force, and the first generic applications are expected to be approved sometime in late 2025 or early 2026—once the exclusivity period expires and the FDA clears the generic.
Below is a quick guide to why that is the case and how you can stay informed.
Bottom line: In the U.S. you’ll still see only the branded Xarelto until the 5‑year data exclusivity period ends (around 2029‑2030 for the first generic), but the patents themselves expire a bit earlier. The U.S. regulatory environment (FDA) is what ultimately determines when the generic hits the shelves.
If you need the drug urgently and the brand is the only option, your prescriber can keep you on Xarelto until the generic becomes available. Once the generic hits the shelves, you can switch for cost savings without compromising safety or efficacy.
Feel free to reach out if you want help monitoring for the exact approval date or if you’re looking for a specific pharmacy’s price.
Other Questions About Xarelto :